Embed from Getty ImagesBy David GrantFor those currently on PrEP, the days of having to take a pill every day could be numbered.Massachusetts-based pharmaceutical company Intarcia Therapeutics is moving forward with plans to market a subcutaneous device that would deliver a daily dose of the anti-retroviral medicine.They’ve just secured $206 million in funding to better research…
“We’re living through war, but where they’re living it’s peace time, and we’re all in the same country.”
New targeted interventions can have a significant impact on reducing the spread HIV and reducing the risk young women face of becoming HIV positive in South Africa.
Sadly, many of these writers are no longer with us, but their works live on, serving as both educational tools and as unique time capsules for one of the darkest chapters in LGBTQ history.
LGTBI rights in Africa get some help from science.
There’s now a home test for finding out your HIV-status and Shadley Grei hopes you never use it.
Mike Sliwa believes blame has replaced responsibility and therefore reinforced dominant points of view.
Jeremy Feist insists that progress comes not from screaming into the Internet echo chamber, but rather through open and vulnerable dialogue.
Kathryn DeHoyos shares the most important thing she ever learned about sex.
Why do you vote? (Or don’t, as the case may be.)
Cameron Conaway explores the human rights abuses in Chittagong’s notorious shipbreaking yards. Photographs by Pierre Torset.
A new ballot initiative in San Francisco could ban male circumcision in the city. Is this a win for “intactivists”?
Even after two decades of living with HIV, the ex–NBA star continues the charge to raise awareness, change perceptions, and find a cure.
December 1 is World AIDS Day, and organizations are investing significant time and money into Facebook pages and YouTube channels. But will these tools reach the populations most vulnerable to the disease?